NewEdge Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.6M | Buy |
229,158
+16,606
| +8% | +$3.3M | 0.71% | 28 |
|
|
2025
Q1 | $44.5M | Buy |
212,552
+9,428
| +5% | +$1.98M | 0.81% | 27 |
|
|
2024
Q4 | $36.1M | Buy |
203,124
+14,422
| +8% | +$2.56M | 0.63% | 37 |
|
|
2024
Q3 | $37.3M | Buy |
188,702
+73,358
| +64% | +$14.5M | 0.67% | 35 |
|
|
2024
Q2 | $19.8M | Buy |
115,344
+71,123
| +161% | +$12.2M | 0.43% | 62 |
|
|
2024
Q1 | $7.11M | Sell |
44,221
-2,164
| -5% | -$348K | 0.16% | 129 |
|
|
2023
Q4 | $7.19M | Sell |
46,385
-40,992
| -47% | -$6.35M | 0.18% | 121 |
|
|
2023
Q3 | $13M | Buy |
87,377
+8,675
| +11% | +$1.29M | 0.41% | 72 |
|
|
2023
Q2 | $10.6M | Buy |
78,702
+12,823
| +19% | +$1.73M | 0.35% | 82 |
|
|
2023
Q1 | $10.5M | Buy |
65,879
+1,739
| +3% | +$277K | 0.4% | 75 |
|
|
2022
Q4 | $10.4M | Buy |
64,140
+6,036
| +10% | +$975K | 0.45% | 62 |
|
|
2022
Q3 | $7.8M | Buy |
58,104
+59
| +0.1% | +$7.92K | 0.37% | 79 |
|
|
2022
Q2 | $8.89M | Buy |
58,045
+24,066
| +71% | +$3.69M | 0.4% | 70 |
|
|
2022
Q1 | $5.51M | Buy |
33,979
+30,981
| +1,033% | +$5.02M | 0.24% | 102 |
|
|
2021
Q4 | $406K | Buy |
2,998
+599
| +25% | +$81.1K | 0.02% | 314 |
|
|
2021
Q3 | $259K | Buy |
2,399
+79
| +3% | +$8.53K | 0.02% | 259 |
|
|
2021
Q2 | $261K | Buy |
+2,320
| New | +$261K | 0.02% | 254 |
|